120 related articles for article (PubMed ID: 8797721)
1. The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders.
Waldmann TA
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S179-85. PubMed ID: 8797721
[TBL] [Abstract][Full Text] [Related]
2. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Waldmann TA
Important Adv Oncol; 1994; ():131-41. PubMed ID: 8206486
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.
Tendler CL; Greenberg SJ; Blattner WA; Manns A; Murphy E; Fleisher T; Hanchard B; Morgan O; Burton JD; Nelson DL
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5218-22. PubMed ID: 2367534
[TBL] [Abstract][Full Text] [Related]
4. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
Azimi N; Jacobson S; Leist T; Waldmann TA
J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
[TBL] [Abstract][Full Text] [Related]
5. 1992 Stohlman Memorial Lecture: targeting the IL-2 receptor.
Waldmann TA
Leukemia; 1993 Aug; 7 Suppl 2():S151-6. PubMed ID: 8361223
[TBL] [Abstract][Full Text] [Related]
6. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptors for cytokines: targets for immunotherapy of leukemia/lymphoma.
Waldmann TA
Ann Oncol; 2000; 11 Suppl 1():101-6. PubMed ID: 10707789
[TBL] [Abstract][Full Text] [Related]
8. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine receptors: a target for immunotherapy of lymphomas.
Waldmann TA
Ann Oncol; 1994; 5 Suppl 1():13-7. PubMed ID: 8172810
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic expression of heterologous cytokine/receptor genes in HTLV-1 associated diseases: candidate TRS for chimeric gene therapy.
Greenberg SJ; Choi U; Overturf PM; Glenister N; Robinson TA; Lis A; Hohmann P; Goldman BD; Oseroff AR; Plunkett RJ
Leukemia; 1997 Apr; 11 Suppl 3():79-81. PubMed ID: 9209305
[TBL] [Abstract][Full Text] [Related]
11. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
13. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
14. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy.
Waldmann TA
Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734
[TBL] [Abstract][Full Text] [Related]
15. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
17. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
18. Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: a potential role in HTLV-I pathogenesis.
Marriott SJ; Trinh D; Brady JN
Oncogene; 1992 Sep; 7(9):1749-55. PubMed ID: 1501887
[TBL] [Abstract][Full Text] [Related]
19. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells.
Kannagi M; Matsushita S; Harada S
Int J Cancer; 1993 Jun; 54(4):582-8. PubMed ID: 8514449
[TBL] [Abstract][Full Text] [Related]
20. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
